Clover Health 3Q 2026: Revenue $759.3M, EPS $0.01 — 10-Q Summary
Clover Health reported 3Q 2026 revenue of $759.3M, up 53% YoY, and net income of $6.44M, reversing a prior-year loss. Growth was driven by Medicare Advantage membership and higher premiums, but offset by increased medical and administrative costs. EPS was $0.01.
How this was made
The 30-second read
Why it matters
The earnings surprise could trigger short covering and buying interest, especially from investors focused on turnaround stories.
Market read
First‑report earnings with a profit swing; likely to move CLOV stock in after‑hours trading.
What to watch
Higher per‑member premiums could face regulatory scrutiny.
Background
Clover Health filed its 10‑Q for Q3 2026, highlighting strong membership growth and premium increases.
Ticker impact
Clover Health reported Q3 2026 revenue of $759.3M and a swing to $6.44M net income, marking a material earnings surprise.
likely upward pressure as the market prices in the earnings beat and profit swing
Revenue grew 53% YoY and net income turned positive; investors typically reward such turnaround.
Market effects
Positive signal for the Medicare Advantage and health‑tech sector.
U.S. healthcare stocks may see modest gains.
Limited to U.S. markets; no direct global impact.
Counterpoint
Profitability may be temporary if medical cost inflation accelerates.
Key entities
- companyClover Health
U.S. Medicare Advantage insurer (ticker CLOV).
